Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle 7-related protein kinase (CDC7) is a serine/threonine protein kinase essential for the initiation of DNA replication during the cell cycle. It phosphorylates components of the minichromosome maintenance (MCM) complex, allowing DNA replication to begin. CDC7's overexpression is linked to tumorigenesis, making it a therapeutic target in oncology. Inhibiting CDC7 impairs cancer cells' ability to respond to replication stress, leading to DNA damage and apoptosis. Several inhibitors, such as SGR-2921, are under clinical investigation. CDC7 expression peaks functionally during S phase and is regulated post-transcriptionally by microRNAs. The CDC7 gene is highly conserved across eukaryotes.
Selective inhibition of CDC7 kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 7-related protein kinase (CDC7).